High-dose methotrexate in ICU patients: a retrospective study

BACKGROUND: High-dose methotrexate (HD-MTX) is commonly used in the treatment of solid tumors and hematological malignancies. Severe toxicities are frequent, leading to organ dysfunction and death. Risk–benefit ratio of using HD-MTX in critically ill patients is unknown. This study aims to describe...

Descripción completa

Detalles Bibliográficos
Autores principales: Valade, Sandrine, Mariotte, Eric, Azoulay, Elie, Darmon, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293713/
https://www.ncbi.nlm.nih.gov/pubmed/32535662
http://dx.doi.org/10.1186/s13613-020-00693-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293713/
https://www.ncbi.nlm.nih.gov/pubmed/32535662
http://dx.doi.org/10.1186/s13613-020-00693-5

Ejemplares similares